Christine Berni Silverstein

This profile gathers the share dealings of Christine Berni Silverstein across 2 companies, led by Abeona Therapeutics Inc. and Marinus Pharmaceuticals, Inc. In total, 18 filings cover trades dated from 20 May 2020 to 15 June 2026.

No open-market purchase appears, only 5 sales worth €373k. Outside the open market, there are 11 share grants. In 2026 alone, the filings show no purchases and 2 sales.

On 15 June 2026 came the latest disclosure, an open-market sale for €89k in Abeona Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.